×

Acorda CEO strikes back to Kyle Bass

5:44 PM ET Wed, 16 Sept 2015

Ron Cohen, Acorda Therapeutics CEO, joins CNBC's Meg Tirrell for an exclusive interview to discuss drug patents and respond to claims made by Hayman Capitals Kyle Bass regarding his fight against drug patents.